Bicarbonate

Bicarbonate

SCHEMBL1490993

CCCC[n+]1ccn(C)c1.O=C([O-])[O-].[H+]

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.40
HSP90AA1 P07900 1/20 0.40
KMT2A Q03164 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
PABPC1 P11940 1/20 0.36
FDPS P14324 7/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bicarbonate SCHEMBL5032083 0.98 MEN1 (0.41) MEN1HSP90AA1KMT2ASMN1; SMN2PABPC1
Bicarbonate SCHEMBL23698434 0.94 MEN1 (0.44) MEN1HSP90AA1KMT2ASMN1; SMN2
Bicarbonate SCHEMBL6265469 0.94 MEN1 (0.44) MEN1HSP90AA1KMT2ASMN1; SMN2
Acetic Acid SCHEMBL35015 0.93 MEN1 (0.43) MEN1HSP90AA1KMT2ASMN1; SMN2PABPC1
Bicarbonate SCHEMBL2127090 0.93 MEN1 (0.40) MEN1HSP90AA1KMT2ASMN1; SMN2PABPC1
Bicarbonate SCHEMBL28733245 0.92 MEN1 (0.46) MEN1HSP90AA1KMT2ASMN1; SMN2
Propionic Acid SCHEMBL358643 0.92 MEN1 (0.39) MEN1HSP90AA1KMT2ASMN1; SMN2PABPC1
Bicarbonate SCHEMBL28939212 0.92 MEN1 (0.46) MEN1HSP90AA1KMT2ASMN1; SMN2
Glycolic Acid SCHEMBL18575074 0.90 MEN1 (0.38) MEN1HSP90AA1KMT2ASMN1; SMN2PABPC1
Succinic Acid SCHEMBL18575091 0.90 CA1 (0.40) MEN1HSP90AA1KMT2ASMN1; SMN2PABPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111117594-A Electrochromic material based on dynamic metal-ligand complexation and electrochromic device 吉林大学 2020-05-08 CN claimed
US-9394388-B2 Hybrid supported metallocene catalyst, method for preparing the same, and process for preparing polyolefin using the same SK INNOVATION CO., LTD. (KR) 2016-07-19 US claimed
US-20150025204-A1 Hybrid Supported Metallocene Catalyst, Method for Preparing the Same, and Process for Preparing Polyolefin Using the Same SK INNOVATION CO., LTD. (KR) 2015-01-22 US claimed
WO-2013133595-A1 HYBRID SUPPORTED METALLOCENE CATALYST, METHOD FOR PREPARING THE SAME, AND PROCESS FOR PREPARING POLYOLEFIN USING THE SAME SK INNOVATION CO., LTD. (KR) 2013-09-12 WO claimed
US-12291506-B2 Method for producing amidate compound, and amidate compound KOEI CHEMICAL COMPANY, LIMITED (JP) 2025-05-06 US disclosed
CN-115074109-A Electrochromic material and device 吉林大学 2022-09-20 CN disclosed
EP-3512905-B1 METHOD FOR PRODUCING A POLYBENZAZOL POLYMER (P) BASF SE (DE) 2022-08-24 EP disclosed
CN-107710462-B Electrochemical hydrogen storage electrode and battery 巴斯夫公司 2022-08-02 CN disclosed
US-20220048864-A1 METHOD FOR PRODUCING AMIDATE COMPOUND, AND AMIDATE COMPOUND KOEI CHEMICAL COMPANY, LIMITED (JP) 2022-02-17 US disclosed
CN-107615556-B Electrolyte and metal hydride battery 巴斯夫公司 2021-11-02 CN disclosed
EP-3858817-A1 METHOD FOR PRODUCING AMIDATE COMPOUND, AND AMIDATE COMPOUND Koei Chemical Company, Limited (JP) 2021-08-04 EP disclosed
CN-111117594-A Electrochromic material based on dynamic metal-ligand complexation and electrochromic device 吉林大学 2020-05-08 CN disclosed
EP-2515827-A2 CURABLE DENTAL COMPOSITIONS AND ARTICLES COMPRISING POLYMERIZABLE IONIC LIQUIDS 3M Innovative Properties Company (US) 2012-10-31 EP disclosed
EP-2470509-A2 COMPOSITIONS AND ARTICLES COMPRISING POLYMERIZABLE IONIC LIQUID MIXTURE, AND METHODS OF CURING 3M Innovative Properties Company (US) 2012-07-04 EP disclosed
WO-2012078783-A2 IMMOBILIZATION OF IONIC LIQUIDS VIA MECHNOCHEMICAL INTERCALATION IN LAYERED MATERIALS TEXAS STATE UNIVERSITY-SAN MARCOS (US) 2012-06-14 WO disclosed
US-20120101184-A1 COMPOSITIONS AND ARTICLES COMPRISING POLYMERIZABLE IONIC LIQUID MIXTURE, AND METHODS OF CURING 3M INNOVATIVE PROPERTIES COMPANY 2012-04-26 US disclosed
WO-2011091131-A2 ESLICARBAZEPINE ACETATE AND ITS POLYMORPHS DR. REDDY'S LABORATORIES LTD. (IN) 2011-07-28 WO disclosed
WO-2011087621-A2 CURABLE DENTAL COMPOSITIONS AND ARTICLES COMPRISING POLYMERIZABLE IONIC LIQUIDS 3M INNOVATIVE PROPERTIES COMPANY (US) 2011-07-21 WO disclosed
WO-2011025847-A2 COMPOSITIONS AND ARTICLES COMPRISING POLYMERIZABLE IONIC LIQUID MIXTURE, AND METHODS OF CURING 3M INNOVATIVE PROPERTIES COMPANY (US) 2011-03-03 WO disclosed
US-20100213402-A1 ELECTROLYTE COMPOSITION AND IONIC LIQUID KANEKA CORPORATION (JP) 2010-08-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120101184-A1 COMPOSITIONS AND ARTICLES COMPRISING POLYMERIZABLE IONIC LIQUID MIXTURE, AND METHODS OF CURING ELOVL3, ELOVL6, ELOVL1 MEN1 2260/4885HSP90AA1 4725/4885KMT2A 3855/4885
US-12291506-B2 Method for producing amidate compound, and amidate compound NAAA, NIT2, PAM MEN1 55/4885HSP90AA1 4241/4885KMT2A 4207/4885
US-20220048864-A1 METHOD FOR PRODUCING AMIDATE COMPOUND, AND AMIDATE COMPOUND NAAA, NIT2, PAM MEN1 55/4885HSP90AA1 4241/4885KMT2A 4207/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.